SCHEMBL14097700

SCHEMBL14097700

CCNC(=S)Nc1nc2cc(-c3ccccc3)ccc2o1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ FAAH O00519 2/20 0.45
▸ CHIA Q9BZP6 1/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ ABL1 P00519 3/20 0.43
▸ HDAC6 Q9UBN7 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ LIPG Q9Y5X9 1/20 0.41
▸ DGAT1 O75907 1/20 0.41
▸ FBP1 P09467 1/20 0.41
▸ CETP P11597 1/20 0.41
▸ AGPAT2 O15120 1/20 0.41
▸ IL6 P05231 1/20 0.40
▸ STAT3 P40763 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14097679 0.85 ABL1 (0.59) GAAL3MBTL1FAAHSMN1; SMN2ABL1
SCHEMBL14395652 0.79 GAA (0.48) GAAL3MBTL1FAAHCHIASMN1; SMN2
SCHEMBL14097676 0.77 SMN1; SMN2 (0.58) GAAL3MBTL1FAAHSMN1; SMN2HDAC6
SCHEMBL12162598 0.76 GAA (0.52) GAAL3MBTL1FAAHSMN1; SMN2HDAC6
SCHEMBL14097682 0.74 ABL1 (0.60) SMN1; SMN2ABL1HDAC6KDM4ENPC1
SCHEMBL14097401 0.73 ABL1 (0.61) SMN1; SMN2ABL1KDM4ENPC1MAPT
SCHEMBL14097688 0.71 ABL1 (0.49) ABL1HDAC6RAB9ACETPIL6
SCHEMBL14097706 0.69 ABL1 (0.49) ABL1
SCHEMBL12545774 0.69 AAK1 (0.60) GAAL3MBTL1FAAHSMN1; SMN2KDM4E
SCHEMBL1634416 0.68 L3MBTL1 (1.00) GAAL3MBTL1FAAHSMN1; SMN2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
Send feedback